Magnetic resonance imaging and implantable devices

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 2, 2013, Pages 419-428

  Nazarian, Saman ^a   Beinart, Roy ^a   Halperin, Henry R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Implantable cardioverter defibrillator; Magnetic resonance; Pacemaker

Indexed keywords

LEAD;

ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR EQUIPMENT; COMPUTER ASSISTED THERAPY; DEVICE SAFETY; HUMAN; IMAGE QUALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; IN VITRO STUDY; IN VIVO STUDY; MONITOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT SAFETY; PRIORITY JOURNAL; RADIOFREQUENCY;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; PACEMAKER, ARTIFICIAL; REPRODUCIBILITY OF RESULTS;

EID: 84878037358     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000116     Document Type: Article

References (66)

1. Edelman RR. Basic principles of magnetic resonance angiography. Cardiovasc Intervent Radiol. 1992;15:3-13.
2. Hinks RS, Bronskill MJ, Kucharczyk W, Bernstein M, Collick BD, Henkelman RM. MR systems for image-guided therapy. J Magn Reson Imaging. 1998;8:19-25.
3. Irnich W. Risks to pacemaker patients undergoing magnetic resonance imaging examinations. Europace. 2010;12:918-920.
4. Shellock FG, Tkach JA, Ruggieri PM, Masaryk TJ. Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional ("long-bore") and "short-bore" 1.5- and 3.0-Tesla MR systems. J Cardiovasc Magn Reson. 2003;5:387-397.
5. Babouri A, Hedjeidj A. In vitro investigation of eddy current effect on pacemaker operation generated by low frequency magnetic field. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:5684-5687.
6. Nordbeck P, Weiss I, Ehses P, Ritter O, Warmuth M, Fidler F, Herold V, Jakob PM, Ladd ME, Quick HH, Bauer WR. Measuring RF-induced currents inside implants: impact of device configuration on MRI safety of cardiac pacemaker leads. Magn Reson Med. 2009;61:570-578.
7. Yeung CJ, Karmarkar P, McVeigh ER. Minimizing RF heating of conducting wires in MRI. Magn Reson Med. 2007;58:1028-1034.
8. Calcagnini G, Triventi M, Censi F, Mattei E, Bartolini P, Kainz W, Bassen HI. In vitro investigation of pacemaker lead heating induced by magnetic resonance imaging: role of implant geometry. J Magn Reson Imaging. 2008;28:879-886.
9. Mattei E, Triventi M, Calcagnini G, Censi F, Kainz W, Mendoza G, Bassen HI, Bartolini P. Complexity of MRI induced heating on metallic leads: experimental measurements of 374 configurations. Biomed Eng Online. 2008;7:11.
10. Park SM, Kamondetdacha R, Nyenhuis JA. Calculation of MRI-induced heating of an implanted medical lead wire with an electric field transfer function. J Magn Reson Imaging. 2007;26:1278-1285.
11. Nordbeck P, Bauer WR, Warmuth M, Hiller KH, Jakob PM, Ritter O. Mri-related heating at cardiac pacemaker leads in vivo. Circulation. 2009;120:S371-S371.
12. Langman DA, Goldberg IB, Finn JP, Ennis DB. Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI. J Magn Reson Imaging. 2011;33:426-431.
13. Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004;110:475-482.
14. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol. 2001;24:199-205.
15. Nordbeck P, Ritter O, Weiss I, Warmuth M, Gensler D, Burkard N, Herold V, Jakob PM, Ertl G, Ladd ME, Quick HH, Bauer WR. Impact of imaging landmark on the risk of MRI-related heating near implanted medical devices like cardiac pacemaker leads. Magn Reson Med. 2011; 65:44-50.
16. Bottomley PA, Kumar A, Edelstein WA, Allen JM, Karmarkar PV. Designing passive MRI-safe implantable conducting leads with electrodes. Med Phys. 2010;37:3828-3843.
17. Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F, Candinas R, Boesiger P. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J. 2005;26:376-383; discussion 325.
18. Tandri H, Zviman MM, Wedan SR, Lloyd T, Berger RD, Halperin H. Determinants of gradient field-induced current in a pacemaker lead system in a magnetic resonance imaging environment. Heart Rhythm. 2008;5:462-468.
19. Bassen HI, Mendoza GG. In-vitro mapping of E-fields induced near pacemaker leads by simulated MR gradient fields. Biomed Eng Online. 2009;8:39.
20. Gimbel JR, Zarghami J, Machado C, Wilkoff BL. Safe scanning, but frequent artifacts mimicking bradycardia and tachycardia during magnetic resonance imaging (MRI) in patients with an implantable loop recorder (ILR). Ann Noninvasive Electrocardiol. 2005;10:404-408.
21. Medtronic. Insertable cardiac monitor - magnetic resonance imaging (mri) and reveal icms. http://www.medtronic.com/for-healthcare-professionals/products- therapies/cardiac-rhythm/cardiac-monitors-insert/mri-safety-for-implantable- cardiac-devices/mr-conditional/index.htm. Accessed December 15, 2012.
22. St-Jude-Medical. Sjm confirm implantable cardiac monitor. http://www.sjmprofessional.com/Products/Intl/Implantable-Cardiac-Diagnostics/ SJM-Confirm-Implantable-Cardiac-Monitor.aspx. Accessed February 13, 2013.
23. Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J. 1997;134:467-473.
24. Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol. 1996;19:913-919.
25. Sommer T, Lauck G, Schimpf R, von Smekal A, Wolke S, Block W, Gieseke J, Schneider C, Funke HD, Schild H. [MRI in patients with cardiac pacemakers: in vitro and in vivo evaluation at 0.5 tesla]. Rofo. 1998;168:36-43.
26. Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, Träber F, Schneider C, Gieseke J, Jung W, Schild H. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology. 2000;215:869-879.
27. Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, Lüderitz B. Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol. 2001;24(4 pt 1):489-495.
28. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004;43:1315-1324.
29. Del Ojo JL, Moya F, Villalba J, Sanz O, Pavón R, Garcia D, Pastor L. Is magnetic resonance imaging safe in cardiac pacemaker recipients? Pacing Clin Electrophysiol. 2005;28:274-278.
30. Gimbel JR, Bailey SM, Tchou PJ, Ruggieri PM, Wilkoff BL. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol. 2005;28:1041-1046.
31. Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, Strach K, Skowasch D, Vahlhaus C, Litt H, Schild H. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation. 2006;114:1285-1292.
32. Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation. 2006;114:1277-1284.
33. Naehle CP, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H, Luechinger R, Fimmers R, Schild H, Sommer T. Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology. 2008;249:991-1001.
34. Mollerus M, Albin G, Lipinski M, Lucca J. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol. 2008;31: 1241-1245.
35. Naehle CP, Zeijlemaker V, Thomas D, Meyer C, Strach K, Fimmers R, Schild H, Sommer T. Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol. 2009;32:1526-1535.
36. Mollerus M, Albin G, Lipinski M, Lucca J. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol. 2009;32:772-778.
37. Mollerus ME. Clarification to the article 'Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions'. Europace. 2010;12:1798.
38. Halshtok O, Goitein O, Abu Sham'a R, Granit H, Glikson M, Konen E. Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly. Isr Med Assoc J. 2010;12:391-395.
39. Strach K, Naehle CP, Mühlsteffen A, Hinz M, Bernstein A, Thomas D, Linhart M, Meyer C, Bitaraf S, Schild H, Sommer T. Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace. 2010;12:952-960.
40. Burke PT, Ghanbari H, Alexander PB, Shaw MK, Daccarett M, Machado C. A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol. 2010;28:59-66.
41. Buendía F, Sánchez-Gómez JM, Sancho-Tello MJ, Olagüe J, Osca J, Cano O, Arnau MA, Igual B. Nuclear magnetic resonance imaging in patients with cardiac pacing devices. Rev Esp Cardiol. 2010;63:735-739.
42. Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011;155:415-424.
43. Cohen JD, Costa HS, Russo RJ. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators. Am J Cardiol. 2012;110:1631-1636.
44. Boilson BA, Wokhlu A, Acker NG, Felmlee JP, Watson RE Jr, Julsrud PR, Friedman PA, Cha YM, Rea RF, Hayes DL, Shen WK. Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach. J Interv Card Electrophysiol. 2012;33:59-67.
45. Coman JA, Martin ET, Sandler DA, Thomas Jr. Implantable cardiac defibrillator interactions with magnetic resonance imaging at 1.5 tesla. J Am Coll Cardiol. 2004;43:138A-138A.
46. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol. 2005;28:270-273.
47. Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S, Litt H, Schwab JO, Schild H, Sommer T. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol. 2009;54:549-555.
48. Pulver AF, Puchalski MD, Bradley DJ, Minich LL, Su JT, Saarel EV, Whitaker P, Etheridge SP. Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with pacemakers. Pacing Clin Electrophysiol. 2009;32:450-456.
49. Cohen J, Costa H, Russo R. Pacemaker and implantable cardioverter defibrillator safety for patients undergoing magnetic resonance imaging (the magnasafe registry). J Am Coll Cardiol. 2009;53:A303-A304.
50. Cohen JD, Costa HS, Russo RJ. Pacemaker and implantable cardioverter defibrillator safety for patients undergoing magnetic resonance imaging (the magnasafe registry). Circulation. 2008;118:S778-S778.
51. Russo RJ, Costa H, Doud D, Birgersdotter-Green U, Bloomgarden D, Florin T, Lampert R, Machado C, Martin E, Ponce G, Porter M, Schaerf R, Tominaga G, Uretsky S, Wolff S. Repeat mri for patients with implanted cardiac devices does not increase the risk of clinical events or parameter changes: Preliminary results from the magnasafe registry. J Am Coll Cardiol. 2012;59:E649-E649.
52. Goldsher D, Jahshan S, Roguin A. Successful cervical MR scan in a patient several hours after pacemaker implantation. Pacing Clin Electrophysiol. 2009;32:1355-1356.
53. Lauck G, von Smekal A, Wolke S, Seelos KC, Jung W, Manz M, Lüderitz B. Effects of nuclear magnetic resonance imaging on cardiac pacemakers. Pacing Clin Electrophysiol. 1995;18:1549-1555.
54. Luechinger R, Duru F, Zeijlemaker VA, Scheidegger MB, Boesiger P, Candinas R. Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol. 2002;25:1419-1423.
55. Nazarian S, Halperin HR. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm. 2009;6:138-143.
56. Sasaki T, Hansford R, Zviman MM, Kolandaivelu A, Bluemke DA, Berger RD, Calkins H, Halperin HR, Nazarian S. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc Imaging. 2011;4:662-670.
57. Standard practice for marking medical devices and other items for safety in the magnetic resonance environment. Available at: http://enterprise.astm.org/ filtrexx40.cgi?+REDLINE-PAGES/F2503.htm. Accessed December 3, 2012.
58. Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, Heuer H, Hecking K, Johnson WB, Young W, Ramza B, Akhtar N, Kuepper B, Hunold P, Luechinger R, Puererfellner H, Duru F, Gotte MJ, Sutton R, Sommer T; EnRhythm MRI SureScan Pacing System Study Investigators. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm. 2011;8:65-73.
59. Forleo GB, Santini L, Della Rocca DG, Romano V, Papavasileiou LP, Magliano G, Sgueglia M, Romeo F. Safety and efficacy of a new magnetic resonance imaging-compatible pacing system: early results of a prospective comparison with conventional dual-chamber implant outcomes. Heart Rhythm. 2010;7:750-754.
60. St-Jude-Medical. Accent mri pacemaker. http://www.sjmprofessional.com/ products/intl/pacing-systems/accent-mri-pacemaker.aspx. Accessed December 15, 2012.
61. Biotronik. Press release - mr approved crt devices. http://www.biotronik. com/wps/wcm/connect/int-web/biotronik/newsroom/press-releases?p=http://www. biotronik.com/wps/wcm/connect/int-web/biotronik/newsroom/press-releases/ pr-esc-congress-2012-en&pw=770&pt=. Accessed December 15, 2012.
62. Boston-Scientific. Boston scientific ingenio family of pacemakers receives ce mark approval for use in mri scans. http://bostonscientific. mediaroom.com/index.php?s=24889&item=130968. December 15, 2012.
63. Gimbel Jr. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. Pacing Clin Electrophysiol. 2008;31:795-801.
64. Gimbel Jr. Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a 'modern' pacemaker. Europace. 2009;11:1241-1242.
65. Gimbel Jr. Unexpected pacing inhibition upon exposure to the 3T static magnetic field prior to imaging acquisition: what is the mechanism? Heart Rhythm. 2011;8:944-945.
66. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FS. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association Scientific Statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council On Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007;116:2878-2891.